Sopharma AD notifies that due to the refusal issued by the Registry agency for the registration of the transformation through merger of Unipharm AD into Sopharma AD that started in September 2017, the Board of directors of Sopharma AD took a decision to close the previous and start a new procedure for transformation of Sopharma AD under the conditions of Chapter XVI of the Commercial Law and Art.

Sopharma AD notifies that for April 2018 the Company recorded an increase of sales revenues of 12% compared to the same month of 2017, including 1% increase of domestic sales and an increase of 21% of export sales. For the first four months of this year, revenues from sales of products increased by 0,3% compared to the same period of 2017, including 0.5% increase of domestic sales and 0,1% increase of export sales.

Sopharma AD announces that on May 2, 2018 the Registry Agency announced with the number № 20180502120127 the invitation a Regular General Meeting of Shareholders of Sopharma AD, scheduled for 15 June 2018.

Sopharma AD notifies that on April 30, 2018, the Registry Agency issued a refusal № 20180411164207 of the declared transformation of Unipharm AD into Sopharma AD under the Transformation Agreement of September, 14 2017 and the Additional Agreement of November, 8 2017.

The companies are considering to launch a new transformation procedure as soon as possible.

Bulgaria hosts this year’s General assembly of the European Federation of the National Associations of Laboratories for Measurement, Testing and Analysis (EUROLAB)